Opthea Completes COAST Final Week 52 Patient Visit
Posted: 19 February 2025 Opthea Limited (ASX/NASDAQ:OPT, “Opthea”, the “Company”), a clinical-stage biopharmaceutical company developing novel therapies to treat highly prevalent and progressive retinal diseases, including wet age-related macular degeneration (wet AMD), today announced that it has completed the…
Navi Medical Technologies secures FDA Clearance
Posted: 17 February 2025 Breakthrough Victoria portfolio company, Navi Medical Technologies (Navi), has taken a major step in their mission to making hospital care safer for newborn babies and children, receiving FDA clearance for their Neonav® ECG Tip…
Stronger, safer, smarter: pioneering Zinc-based dissolvable implants for bone repair
Posted: 17 February 2025 Monash research could transform how broken bones are treated, with the development of a special zinc-based dissolvable material that could replace the metal plates and screws typically used to hold fractured bones together. Surgeons…
Breakthrough IBD treatment heads into clinical trials
Posted: 17 February 2025 People living with inflammatory bowel disease (IBD) have new hope, with clinical trials beginning for a breakthrough treatment for one of the most difficult to treat conditions associated with the disease. IBD is the collective term…
Groundbreaking Research Sheds Light on Cerebellar Ataxias: Advancing Hope for Balance Disorder Treatment
Posted: 17 February 2025 At the Bionics Institute, we are committed to pushing the boundaries of medical research to address the most pressing and overlooked health challenges. One such challenge are the cerebellar ataxias, a devastating group of…
How advanced drug discovery tech is fast-tracking new treatments
Posted: 17 February 2025 On the same day that the National Drug Discovery Centre was officially launched at WEHI, the World Health Organization declared COVID-19 a pandemic. Within weeks, the NDDC had tested over 400,000 compounds to find starting points…
Illuccix Approved in the United Kingdom
Posted: 14 February 2025 Telix today announces that the United Kingdom (UK) Medicines and Healthcare Products Regulatory Agency (MHRA) has approved the Marketing Authorization Application (MAA) for its prostate cancer PET[1] imaging agent Illuccix® (kit for the preparation of…
New research assists understanding of immune response to cancers, chronic disease
Posted: 13 February 2025 A discovery about the mechanisms that enable the immune system to sustain long-term protection could revolutionise treatment for chronic disease and cancer. Prolonged illnesses like cancer and chronic infections often leave the immune system…
2025 BioSymposium sponsors: Innovations in Technologies – Implantables, Neurotech, and Diagnostics
Web djsir.vic.gov.au/health-tech Email medtech.pharma@ecodev.vic.gov.au About us Victoria is home to world-class health technology companies and is a preferred location for many global leaders including CSL, Moderna, BioNTech, Illumina, Telix Pharmaceuticals and Pfizer. International companies partner with Victoria for its…
A milestone celebration of diversity, innovation, and global impact made in Australia
Posted: 11 February 2025 2025 Women in Leadership Awardees announced On the 10th UN International Day of Women and Girls in STEM, the 2025 BioMelbourne Network Women in Leadership Awards marked an extraordinary milestone: ten years of recognising…
BioMelbourne Network Women in Leadership Awards celebrate diversity, innovation and global impact made in Australia
Posted: 11 February 2025 Making 10 years of celebrating leadership, the BioMelbourne Network Women in Leadership Awards recognise the contribution of three inspiring women advancing global healthcare innovation. BioMelbourne Network proudly announces the recipients of its prestigious 2025…
New “all-tablet” treatment advance for common form of leukaemia
Posted: 10 February 2025 An international study published today in the New England Journal of Medicine provides hope for chronic lymphocytic leukaemia (CLL) patients with a new all-tablet treatment showing impressive results. The AMPLIFY clinical trial included over 800 never-before-treated…
